The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity - Probing the role of the methionine-turn in the metzincin metalloprotease superfamily

被引:38
作者
Butler, GS
Tam, EM
Overall, CM
机构
[1] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1074/jbc.M312727200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are an important family of extracellular proteases that process a variety of biologically significant molecules. MMPs are members of the metzincin superfamily of >770 zinc endopeptidases, which includes astacins, serralysins, adamalysins, leishmanolysins, and snapalysins. Metzincins are characterized by an absolutely conserved methionine residue COOH-terminal to the third histidine in the consensus sequence HEXXHXXGXX(H/D), where the histidine residues chelate a catalytic zinc ion. The canonical methionine is part of a tight 1,4-beta-turn that loops the polypeptide chain beneath the catalytic zinc ion, forming a hydrophobic floor to the Zn2+ ion binding site. The role of this methionine is uncertain, but its absolute conservation indicates an essential catalytic or structural function. To investigate this hypothesis, we replaced Met-392 that forms the Met-turn of human MMP-2 (gelatinase A) by site-directed mutagenesis. The catalytic competence of leucine and serine mutants was assessed. (M392L) MMP-2 and (M392S) MMP-2 cleaved the physiological substrates gelatin, native type I collagen, and the chemokine monocyte chemoattractant protein-3 with similar efficiency to wild-type MMP-2. These mutants also cleaved two quenched fluorescent peptide substrates with a k(cat)/K-m comparable to wild-type MMP-2 and underwent 4-aminophenylmercuric acetate-induced autoactivation with similar kinetics. (M392L) MMP-2 and (M392S) MMP-2 were inhibited by tissue inhibitor of metalloproteinases (TIMP)-1, -2, and -4 and by the zinc chelators 1,10-phenanthroline and a synthetic hydroxamate inhibitor, Batimastat, similar to the wild-type protein, indicating an unaltered active site topography. A tryptic susceptibility assay also suggested that (M392L) MMP-2 and (M392S) MMP-2 were correctly folded. These results challenge the dogma that this methionine residue and the Met-turn, which are absolutely conserved in all of the subfamilies of the metzincins, play an essential role in catalysis or active site structure.
引用
收藏
页码:15615 / 15620
页数:6
相关论文
共 38 条
  • [1] Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes
    Atkinson, SJ
    Crabbe, T
    Cowell, S
    Ward, RV
    Butler, MJ
    Sato, H
    Seiki, M
    Reynolds, JJ
    Murphy, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) : 30479 - 30485
  • [2] Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
    Balbín, M
    Fueyo, A
    Tester, AM
    Pendás, AM
    Pitiot, AS
    Astudillo, A
    Overall, CM
    Shapiro, SD
    López-Otín, C
    [J]. NATURE GENETICS, 2003, 35 (03) : 252 - 257
  • [3] Bigg HF, 2001, CANCER RES, V61, P3610
  • [4] Structural properties of matrix metalloproteinases
    Bode, W
    Fernandez-Catalan, C
    Tschesche, H
    Grams, F
    Nagase, H
    Maskos, K
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (04) : 639 - 652
  • [5] ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS
    BODE, W
    GOMISRUTH, FX
    STOCKLER, W
    [J]. FEBS LETTERS, 1993, 331 (1-2) : 134 - 140
  • [6] Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis - Potential role in human MBL deficiency
    Butler, GS
    Sim, D
    Tam, E
    Devine, D
    Overall, CM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) : 17511 - 17519
  • [7] Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases
    Cawson, T
    [J]. MOLECULAR MEDICINE TODAY, 1998, 4 (03): : 130 - 137
  • [8] Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis
    Curran, S
    Murray, GI
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) : 1621 - 1630
  • [9] New functions for the matrix metalloproteinases in cancer progression
    Egeblad, M
    Werb, Z
    [J]. NATURE REVIEWS CANCER, 2002, 2 (03) : 161 - 174
  • [10] Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects
    Fingleton, B
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) : 385 - 397